Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP642217.RAUjldIvNEpgjrgyjSUW8Y37_MG2EGcWt1sgtYMFRan6M130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP642217.RAUjldIvNEpgjrgyjSUW8Y37_MG2EGcWt1sgtYMFRan6M130_assertion type Assertion NP642217.RAUjldIvNEpgjrgyjSUW8Y37_MG2EGcWt1sgtYMFRan6M130_head.
- NP642217.RAUjldIvNEpgjrgyjSUW8Y37_MG2EGcWt1sgtYMFRan6M130_assertion description "[Effective clinical treatment with anti-CD19 CAR T cells was first reported in 2010 after a patient with advanced-stage lymphoma treated at the NCI experienced a partial remission of lymphoma and long-term eradication of normal B cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP642217.RAUjldIvNEpgjrgyjSUW8Y37_MG2EGcWt1sgtYMFRan6M130_provenance.
- NP642217.RAUjldIvNEpgjrgyjSUW8Y37_MG2EGcWt1sgtYMFRan6M130_assertion evidence source_evidence_literature NP642217.RAUjldIvNEpgjrgyjSUW8Y37_MG2EGcWt1sgtYMFRan6M130_provenance.
- NP642217.RAUjldIvNEpgjrgyjSUW8Y37_MG2EGcWt1sgtYMFRan6M130_assertion SIO_000772 23546520 NP642217.RAUjldIvNEpgjrgyjSUW8Y37_MG2EGcWt1sgtYMFRan6M130_provenance.
- NP642217.RAUjldIvNEpgjrgyjSUW8Y37_MG2EGcWt1sgtYMFRan6M130_assertion wasDerivedFrom befree-20150227 NP642217.RAUjldIvNEpgjrgyjSUW8Y37_MG2EGcWt1sgtYMFRan6M130_provenance.
- NP642217.RAUjldIvNEpgjrgyjSUW8Y37_MG2EGcWt1sgtYMFRan6M130_assertion wasGeneratedBy ECO_0000203 NP642217.RAUjldIvNEpgjrgyjSUW8Y37_MG2EGcWt1sgtYMFRan6M130_provenance.